Cigna Group/$CI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Ticker
$CI
Sector
Primary listing
NYSE
Employees
72,398
Headquarters
Website
Cigna Group Metrics
BasicAdvanced
$79B
16.29
$18.24
0.49
$5.82
2.03%
Price and volume
Market cap
$79B
Beta
0.49
52-week high
$365.58
52-week low
$256.89
Average daily volume
1.6M
Dividend rate
$5.82
Financial strength
Current ratio
0.788
Quick ratio
0.642
Long term debt to equity
65.496
Total debt to equity
76.102
Dividend payout ratio (TTM)
31.63%
Interest coverage (TTM)
7.04%
Profitability
EBITDA (TTM)
11,408
Gross margin (TTM)
9.86%
Net profit margin (TTM)
1.92%
Operating margin (TTM)
3.73%
Effective tax rate (TTM)
21.37%
Revenue per employee (TTM)
$3,620,000
Management effectiveness
Return on assets (TTM)
3.98%
Return on equity (TTM)
13.18%
Valuation
Price to earnings (TTM)
16.294
Price to revenue (TTM)
0.307
Price to book
1.97
Price to tangible book (TTM)
-2.41
Price to free cash flow (TTM)
24.605
Free cash flow yield (TTM)
4.06%
Free cash flow per share (TTM)
12.076
Dividend yield (TTM)
1.96%
Forward dividend yield
2.03%
Growth
Revenue change (TTM)
20.23%
Earnings per share change (TTM)
43.31%
3-year revenue growth (CAGR)
13.45%
10-year revenue growth (CAGR)
21.74%
3-year earnings per share growth (CAGR)
2.76%
10-year earnings per share growth (CAGR)
8.49%
3-year dividend per share growth (CAGR)
11.14%
10-year dividend per share growth (CAGR)
64.55%
What the Analysts think about Cigna Group
Analyst ratings (Buy, Hold, Sell) for Cigna Group stock.
Bulls say / Bears say
Evernorth revenue rose 17% year-over-year to $57.83 billion in Q2 2025, driven by robust growth in its pharmacy benefit management and specialty pharmacy services (Reuters)
Cigna reported Q2 adjusted EPS of $7.20, surpassing the $7.15 consensus estimate, and reaffirmed its full-year guidance of at least $29.60 per share, underscoring resilient profitability (Reuters)
Total Q2 2025 revenue of $67.2 billion exceeded analysts’ projection of $62.7 billion, reflecting strong demand and execution across its health services and PBM segments (Barron's)
FTC preparing to resume its insulin pricing lawsuit against Cigna’s Express Scripts could expose the company to significant legal liabilities and reputational damage if allegations of steering patients toward higher-priced drugs are upheld (Reuters)
Arkansas Governor’s recent legislation to ban PBMs from owning pharmacies directly targets Express Scripts’ vertical integration model and, if upheld, may spur similar state-level restrictions that erode Cigna’s competitive moat (Financial Times)
CFRA warns that industry-wide medical cost pressures will persist in 2025, forecasting Cigna’s medical cost ratio to average 83.2%–84.2%, which could materially compress margins in its healthcare segment (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Cigna Group Financial Performance
Revenues and expenses
Cigna Group Earnings Performance
Company profitability
Cigna Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept18
Cigna Group
DividendPayment
$1.51Per share
FAQs
What’s the current market cap for Cigna Group stock?
Cigna Group (CI) has a market cap of $79B as of September 17, 2025.
What is the P/E ratio for Cigna Group stock?
The price to earnings (P/E) ratio for Cigna Group (CI) stock is 16.29 as of September 17, 2025.
Does Cigna Group stock pay dividends?
Yes, the Cigna Group (CI) stock pays dividends to shareholders. As of September 17, 2025, the dividend rate is $5.82 and the yield is 2.03%. Cigna Group has a payout ratio of 31.63% on a trailing twelve-month basis.
When is the next Cigna Group dividend payment date?
The next Cigna Group (CI) dividend payment is scheduled for September 18, 2025.
What is the beta indicator for Cigna Group?
Cigna Group (CI) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.